JP2004529117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004529117A5 JP2004529117A5 JP2002571052A JP2002571052A JP2004529117A5 JP 2004529117 A5 JP2004529117 A5 JP 2004529117A5 JP 2002571052 A JP2002571052 A JP 2002571052A JP 2002571052 A JP2002571052 A JP 2002571052A JP 2004529117 A5 JP2004529117 A5 JP 2004529117A5
- Authority
- JP
- Japan
- Prior art keywords
- antagonist
- histamine
- medicament
- preparation
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26735201P | 2001-02-08 | 2001-02-08 | |
| PCT/US2002/003975 WO2002072093A2 (en) | 2001-02-08 | 2002-02-06 | Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004529117A JP2004529117A (ja) | 2004-09-24 |
| JP2004529117A5 true JP2004529117A5 (https=) | 2005-12-22 |
Family
ID=23018432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002571052A Pending JP2004529117A (ja) | 2001-02-08 | 2002-02-06 | 認知欠陥障害の処置における二重のｈ３／ｍ２アンタゴニストの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6906081B2 (https=) |
| EP (1) | EP1408965A2 (https=) |
| JP (1) | JP2004529117A (https=) |
| AU (1) | AU2002253929A1 (https=) |
| CA (1) | CA2436083A1 (https=) |
| WO (1) | WO2002072093A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03008356A (es) | 2001-03-13 | 2003-12-11 | Schering Corp | Compuestos del tipo no imidazol como antagonistas de histamina h3. |
| IL165863A0 (en) | 2002-06-24 | 2006-01-15 | Schering Corp | Indole derivatives useful as histamine H3 antagonists |
| WO2004066960A2 (en) * | 2003-01-28 | 2004-08-12 | Schering Corporation | Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| JP2006528147A (ja) * | 2003-07-18 | 2006-12-14 | グラクソ グループ リミテッド | ヒスタミンｈ３受容体リガンドとしての置換ピペリジン |
| GB0420831D0 (en) | 2004-09-17 | 2004-10-20 | Glaxo Group Ltd | Novel compounds |
| US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
| WO2006036686A2 (en) * | 2004-09-24 | 2006-04-06 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
| US8541452B2 (en) * | 2005-10-06 | 2013-09-24 | Guy Chouinard | Method for treating binge-eating disorder |
| US7728031B2 (en) | 2006-02-24 | 2010-06-01 | Abbott Laboratories | Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
| CN101809021B (zh) | 2007-09-11 | 2013-04-24 | 雅培制药有限公司 | 八氢-吡咯并[3,4-b]吡咯n-氧化物 |
| AU2009229372C1 (en) * | 2008-03-27 | 2017-02-02 | Chase Pharmaceuticals Corporation | Use and composition for treating dementia |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| BR112015004902A2 (pt) | 2012-09-05 | 2017-07-04 | Chase Pharmaceuticals Corp | métodos e composição neutroprotetores anticolinérgicos |
| WO2022113008A1 (en) * | 2020-11-27 | 2022-06-02 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2624734A (en) * | 1950-04-29 | 1953-01-06 | Hoffmann La Roche | Bipiperidine derivatives |
| GB8916947D0 (en) | 1989-07-25 | 1989-09-13 | Smith Kline French Lab | Medicaments |
| GB9115740D0 (en) | 1991-07-20 | 1991-09-04 | Smithkline Beecham Plc | Medicaments |
| US5633250A (en) | 1991-12-18 | 1997-05-27 | Schering Corporation | Imidazoylalkyl substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms |
| US5463074A (en) | 1991-12-18 | 1995-10-31 | Schering Corporation | Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
| US5807872A (en) | 1992-12-16 | 1998-09-15 | Schering Corporation | Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
| US5352707A (en) | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
| US5446057A (en) | 1993-09-24 | 1995-08-29 | Warner-Lambert Company | Substituted tetrahydropyridine and piperidine carboxylic acids as muscarinic antagonists |
| JPH09505298A (ja) | 1993-11-15 | 1997-05-27 | シェーリング コーポレイション | Ｈ▲下３▼‐レセプターアンタゴニストとしてのフェニル‐アルキルイミダゾール |
| US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| US5935958A (en) | 1996-07-01 | 1999-08-10 | Schering Corporation | Muscarinic antagonists |
| US5952349A (en) | 1996-07-10 | 1999-09-14 | Schering Corporation | Muscarinic antagonists for treating memory loss |
| US5977138A (en) | 1996-08-15 | 1999-11-02 | Schering Corporation | Ether muscarinic antagonists |
| US6034251A (en) | 1997-11-07 | 2000-03-07 | Schering Corporation | Phenyl-alkyl-imidazoles |
| US5990147A (en) | 1997-11-07 | 1999-11-23 | Schering Corporation | H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| US6066636A (en) | 1998-06-30 | 2000-05-23 | Schering Corporation | Muscarinic antagonists |
| US6100279A (en) | 1998-11-05 | 2000-08-08 | Schering Corporation | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| US6294554B1 (en) | 1999-09-22 | 2001-09-25 | Schering Corporation | Muscarinic antagonists |
-
2002
- 2002-02-06 AU AU2002253929A patent/AU2002253929A1/en not_active Abandoned
- 2002-02-06 WO PCT/US2002/003975 patent/WO2002072093A2/en not_active Ceased
- 2002-02-06 JP JP2002571052A patent/JP2004529117A/ja active Pending
- 2002-02-06 US US10/072,340 patent/US6906081B2/en not_active Expired - Fee Related
- 2002-02-06 EP EP02723129A patent/EP1408965A2/en not_active Withdrawn
- 2002-02-06 CA CA002436083A patent/CA2436083A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007145875A5 (https=) | ||
| JP2004529117A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| MY130803A (en) | New quinuclidine amide derivatives | |
| JP2009502743A5 (https=) | ||
| EP2036902A3 (en) | Urea compounds active as vanilloid receptor antagonist for the treatment of pain | |
| JP2004504376A5 (https=) | ||
| JP2019503365A5 (https=) | ||
| NZ522326A (en) | Adenosine A2A receptor antagonists | |
| HUP0500107A3 (en) | 1-alkyl-1-azoniabicyclo[2.2.2.]octane carbamate derivatives, pharmaceutical compositions comprising thereof and their use as muscarinic receptor antagonists | |
| JP2007514005A5 (https=) | ||
| IL171591A (en) | Quinuclidine derivatives, process for their preparation and use thereof for the manufacture of medicaments for the treatment of conditions mediated by the muscarinic m3 receptor | |
| UA85541C2 (ru) | Карбаматные производные хинуклидина и фармацевтическая композиции, которая содержит эти соединения | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| IL164440A0 (en) | New pharmaceutical composition containing fibanserin polymorph a | |
| JP2008513510A5 (https=) | ||
| HUP0401805A2 (hu) | Pulmonális betegségek kezelésére szolgáló vegyületek | |
| JP2007502832A5 (https=) | ||
| JP2008538583A5 (https=) | ||
| TW200519101A (en) | Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | |
| WO2007067875A3 (en) | Pyridinyl sulfonamide modulators of chemokine receptors | |
| AU2003214535A8 (en) | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists | |
| ATE386738T1 (de) | Flavaxat-derivate als muscarin-rezeptor antagonisten | |
| WO2005062894A3 (en) | Co-administration of dopamine-receptor binding compounds | |
| HUP0401325A3 (en) | Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds |